Adocia
Products and platforms
- Pipeline
- Technology Platforms
Careers
Partnering
Investors
Media
Contact
- Contact us
- Map and accessibility

Investors
Media
- Press releases
- Media

EN
- FR

Adocia and Lilly report positive results of a pilot bioequivalence study comparing BioChaperone Lispro U200 to BioChaperone Lispro U100

Previous articleAdocia announces positive Phase 1b results of BioChaperone® Combo in patients with type 2 diabetes

Next articleAdocia to Hold Conference Call For Investors to Provide 2015 Annual Business Update and Perspectives For 2016

Adocia
Products and platforms
Careers
Partnering
Investors
Media
Contact

Contact us

+33(0)4 72 610 610 contact@adocia.com

Adocia
115 Avenue Lacassagne
69003 Lyon, France

2026 © Adocia

Site plan
Legal notice
Privacy policy and cookies policy
Managing cookies

Website by

Un Brin de Campagne